X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5004) 5004
Book Chapter (89) 89
Book / eBook (69) 69
Dissertation (21) 21
Web Resource (16) 16
Publication (13) 13
Journal / eJournal (10) 10
Book Review (3) 3
Conference Proceeding (3) 3
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3123) 3123
hematological malignancies (2481) 2481
hematology (1844) 1844
male (1733) 1733
female (1715) 1715
oncology (1493) 1493
middle aged (1397) 1397
adult (1344) 1344
cancer (1322) 1322
aged (1092) 1092
leukemia (910) 910
hematological malignancy (748) 748
adolescent (719) 719
chemotherapy (608) 608
transplantation (591) 591
risk factors (506) 506
child (479) 479
young adult (459) 459
acute myeloid-leukemia (457) 457
aged, 80 and over (457) 457
care and treatment (456) 456
retrospective studies (456) 456
haematological malignancies (439) 439
treatment outcome (420) 420
lymphoma (408) 408
analysis (407) 407
research (407) 407
immunology (402) 402
stem cells (397) 397
diagnosis (389) 389
health aspects (387) 387
mortality (378) 378
haematological malignancy (376) 376
infectious diseases (375) 375
lymphomas (364) 364
animals (360) 360
prognosis (358) 358
medicine & public health (347) 347
patients (338) 338
child, preschool (335) 335
epidemiology (328) 328
acute lymphoblastic-leukemia (323) 323
therapy (320) 320
medicine, general & internal (314) 314
children (295) 295
hematopoietic stem cells (283) 283
hematologic neoplasms - complications (280) 280
neutropenia (279) 279
bone-marrow-transplantation (277) 277
survival (275) 275
medicine (271) 271
pharmacology & pharmacy (268) 268
hematologic neoplasms - therapy (262) 262
stem-cell transplantation (257) 257
tumors (255) 255
microbiology (253) 253
multiple myeloma (240) 240
cancer-patients (238) 238
hematopoietic stem cell transplantation (236) 236
prospective studies (232) 232
chronic lymphocytic-leukemia (230) 230
hematologic neoplasms - drug therapy (230) 230
medical research (228) 228
bone marrow (227) 227
multiple-myeloma (225) 225
blood (223) 223
risk (222) 222
infant (218) 218
infections (218) 218
apoptosis (217) 217
risk-factors (215) 215
stem cell transplantation (210) 210
incidence (207) 207
mutation (205) 205
disease (204) 204
cell biology (201) 201
immunotherapy (200) 200
antineoplastic agents - therapeutic use (190) 190
infection (190) 190
antifungal agents - therapeutic use (185) 185
research article (181) 181
review (179) 179
medicine, experimental (173) 173
diseases (172) 172
pediatrics (172) 172
hematological diseases (171) 171
management (167) 167
hematopoietic stem cell transplantation - adverse effects (162) 162
gene expression (161) 161
genetic aspects (161) 161
neutropenic patients (161) 161
expression (160) 160
hemic and lymphatic diseases (160) 160
prophylaxis (159) 159
proteins (158) 158
acute myeloid leukemia (157) 157
malignancy (157) 157
quality of life (157) 157
versus-host-disease (157) 157
antineoplastic combined chemotherapy protocols - therapeutic use (155) 155
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (18) 18
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Gerstein Science - Periodical Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
New College (Ivey) - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4922) 4922
French (70) 70
Russian (63) 63
Japanese (59) 59
Spanish (47) 47
German (28) 28
Polish (20) 20
Czech (10) 10
Turkish (7) 7
Chinese (6) 6
Hungarian (6) 6
Italian (5) 5
Portuguese (3) 3
Arabic (2) 2
Korean (2) 2
Persian (2) 2
Dutch (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current hematologic malignancy reports, ISSN 1558-8211, 2006
Journal
Reviews in clinical and experimental hematology, ISSN 1127-0020, 1997
Journal
Oncogene, ISSN 1476-5594, 2012, Volume 32, Issue 21, pp. 2601 - 2613
.... Several cancers, including blood malignancies, have been associated with constitutive activation of members of the STAT family, which normally require JAK-mediated tyrosine phosphorylation... 
hematological malignancies | leukemia | JAK/STAT | SOCS FAMILY-MEMBERS | COLONY-STIMULATING FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | ERYTHROPOIETIN RECEPTOR ACTIVATION | MYELOPROLIFERATIVE NEOPLASMS | PROTEIN-TYROSINE KINASE | OF-FUNCTION MUTATIONS | CELL BIOLOGY | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENETICS & HEREDITY | ACQUIRED UNIPARENTAL DISOMY | CLASSICAL HODGKIN LYMPHOMA | THROMBOPOIETIN RECEPTOR | Gene Expression Regulation, Enzymologic - drug effects | Janus Kinase 2 - biosynthesis | Hodgkin Disease - genetics | Humans | STAT Transcription Factors - metabolism | Mutation, Missense | Neoplasm Proteins - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Hodgkin Disease - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Hematologic Neoplasms - metabolism | Janus Kinase 2 - antagonists & inhibitors | Hodgkin Disease - metabolism | Signal Transduction | Janus Kinase 2 - genetics | Exons - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | STAT Transcription Factors - genetics | Animals | Gene Expression Regulation, Enzymologic - genetics | Protein Kinase Inhibitors - therapeutic use | Hematologic Neoplasms - drug therapy | Hematologic Neoplasms - genetics | Amino Acid Substitution | Physiological aspects | Lymphomas | Research | Leukemia | Analysis | STAT proteins | Signal transduction | Gene expression | Multiple myeloma
Journal Article
Immunology, ISSN 0019-2805, 2017, Volume 152, Issue 3, pp. 357 - 371
...‐changing activity in various types of solid tumours. Among haematological malignancies, PD... 
pembrolizumab | myeloma | programmed death 1 receptor | haematological malignancy | nivolumab | MULTIPLE-MYELOMA | PROGNOSTIC-FACTORS | DEATH-LIGAND 1 | BRENTUXIMAB VEDOTIN | FOLLICULAR LYMPHOMA | IMMUNOLOGY | IMMUNE CHECKPOINT | CLASSICAL HODGKIN LYMPHOMA | STEM-CELL TRANSPLANTATION | T-CELLS | PD-1 EXPRESSION | Humans | Programmed Cell Death 1 Receptor - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Hematologic Neoplasms - pathology | Evidence-Based Medicine | Molecular Targeted Therapy | B7-H1 Antigen - immunology | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | Hematologic Neoplasms - drug therapy | Hematologic Neoplasms - immunology | Programmed Cell Death 1 Receptor - immunology | Hematologic Neoplasms - metabolism | Monoclonal antibodies | Non-Hodgkin's lymphomas | T cells | Drug approval | Multiple myeloma | Cancer | Corticoids | Drugs | Chronic lymphatic leukemia | Corticosteroids | Hematology | PD-1 protein | Toxicity | Immunomodulation | Leukemia | Lymphocytes T | Lymphoma | Myelodysplastic syndrome | Overexpression | Inhibitors | Lymphocytes B | Chromosome 9 | PD-L1 protein | Lymphomas | Hodgkin's disease | Tumors | B-cell lymphoma | Index Medicus | Review
Journal Article
Journal Article
Journal Article
Journal Article
Journal of hematology and oncology, ISSN 1756-8722, 2018, Volume 11, Issue 1, pp. 65 - 15
.... Increased resistance to apoptosis is a key oncogenic mechanism in several hematological malignancies and, in many cases, especially in lymphoid neoplasias, has been attributed to the upregulation of BCL-2... 
Resistance | BCL-2 | BH3-mimetics | Leukemia | Lymphoma | Hematological malignancies | Venetoclax | Apoptosis | C-MYC | VENETOCLAX VEN | OPEN-LABEL | BH3 MIMETIC ABT-737 | ANTITUMOR-ACTIVITY | PROGRAMMED CELL-DEATH | INHIBITOR NAVITOCLAX | ONCOLOGY | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY | PHASE-I | Antimitotic agents | Physiological aspects | Lymphomas | Genetic aspects | Research | Drug therapy | Antineoplastic agents
Journal Article
Cancer science, ISSN 1347-9032, 2015, Volume 106, Issue 7, pp. 896 - 901
Journal Article